Cornerstone Research
 | |
| Type | Private |
|---|---|
| Industry | Economic Consulting |
| Founded | 1989 |
| Headquarters | San Francisco, California 8 offices in the U.S. and the U.K. |
Key people | Rahul Guha, Chief Executive Officer Yesim C. Richardson, President Cynthia L. Zollinger, Managing Director and Chair |
| Products | Economic Research, Expert Witness Services |
| Revenue | $250 million (est.) |
Number of employees | 700+ |
| Website | www.cornerstone.com |
Cornerstone Research is a litigation consulting firm based in the United States and the United Kingdom. It provides economic and financial analysis and expert testimony to attorneys, corporations and government agencies involved in complex litigation and regulatory proceedings.[1]
Practice areas
Cornerstone Research utilizes both internal and external expert witnesses to provide testimony, utilizing faculty and industry experts.
The company's practice areas include: accounting; antitrust and competition; bankruptcy and financial distress litigation; consumer fraud and product liability; corporate and government investigations; corporate governance; corporate transaction litigation; data analytics; Employee Retirement Income Security Act (ERISA); energy and commodities; financial institutions; intellectual property; international arbitration and litigation; labor and employment; pharmaceuticals and healthcare; real estate; securities; and valuation. Cornerstone was retained by Purdue Pharma in its bankruptcy proceedings.[2][3]
Publications
The firm collaborates on the "Securities Class Action Clearinghouse" in conjunction with the Stanford University Law School.[4] According to a University website, the clearinghouse provides summary information regarding federal class action securities litigation in the United States.[5]
See also
- Analysis Group
- Bates White
- Berkeley Research Group
- Charles River Associates
- NERA Economic Consulting
References
- ^ Cornerstone.com description of services at [1]; last accessed September 15, 2014.
- ^ Brackett, Gary; Salama, Eric (2021). "Purdue Pharma L.P.: A Bankruptcy of Epidemic Proportion". Chapter 11 Bankruptcy Case Studies. 62: 5–106 – via Bankruptcy Law Commons.
- ^ DISCLOSURE STATEMENT FOR CHAPTER 11 PLAN FOR PURDUE PHARMA L.P. AND ITS AFFILIATED DEBTORS. In re Purdue Pharma, 635 B.R. 26 (S.D.N.Y. 2021) Doc. 2488.
- ^ Silicon Valley/San Jose Business Journal article discussing Clearinghouse at smallbusiness.yahoo.com; last accessed July 2, 2022.
- ^ Stanford Law School description of Clearinghouse at Securities.Stanford.edu; last accessed January 16, 2007.